Form D — LeanBio Therapeutics, Inc.
0002160802-26-000001 · filed Oct 22, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b, 4a5
- Reported offering amount
- —
- Reported amount sold
- $0
- Minimum investment
- $0
- Investors
- 0
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- LeanBio Therapeutics, Inc.
- CIK
- 2160802
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 80 PARK STREET
BROOKLINE, MA 02446 - Phone
- 716-6557788
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michal Preminger · Executive OfficerBrookline, MA Find on LinkedIn ↗
-
William Hait · Executive OfficerBrookline, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗